ADC Biotechnology's Private Equity Round

ADC Biotechnology raised a round of funding on September 25, 2017.

ADC Biotechnology is developing new process technology to help drug developers meet conjugation process challenges in the testing and production of new antibody drug conjugate (ADC)-based anti cancer …

Articles about ADC Biotechnology's Private Equity Round: